What is it?
A product blend, not pure salidroside
1On this route, Salidrosol refers to the active listings: a sublingual solution that combines tyrosol and salidroside. It is distinct from whole Rhodiola rosea extract, pure salidroside, and tyrosol alone.
Names, aliases and forms
Mechanisms of action
Rhodiola-constituent rationale
2Salidroside is a Rhodiola-associated phenylethanoid glycoside, while tyrosol is a simple phenolic alcohol. Mechanistic claims around stress resilience, mitochondrial signaling, antioxidant pathways, and fatigue are mostly extrapolated from Rhodiola or salidroside research, not proven for the blended product.
Potential effects and evidence map
Direct human evidence for the Salidrosol tyrosol + salidroside blend was not found. The evidence base is indirect: product-label serving math, Rhodiola traditional-use and extract research, a 2024 exploratory RCT of pure salidroside at 60 mg/day for 16 days in healthy active adults, and a 2025 RCT of Rhodiola root extract standardized to salidroside at 150 mg/day for four weeks alongside eccentric training in recreationally active women. These comparator studies support cautious exercise and fatigue-context interest, not strong focus, memory, mood-disorder, or stress-treatment claims for this blend.
Pure salidroside has exploratory human evidence for exercise-performance and fatigue-related outcomes, but the Salidrosol blend itself has not been directly tested.
Rhodiola has traditional-use and limited clinical context for stress-related fatigue, but this is indirect for a two-compound Salidrosol solution.
The profile evidence review did not identify a direct human trial of the Salidrosol blend for memory, learning, or focus.
Typical dosages and timing
The listing-style dose context is a 0.5 mL serving that supplies salidroside plus tyrosol. The 20 mg per-dose figure is product-label serving math, not clinical proof of efficacy.
Two label-style servings would equal 40 mg/day combined actives. That still differs from the salidroside-only clinical study dose and should not be presented as a validated nootropic protocol.
A 2024 exploratory RCT used 60 mg/day pure salidroside for 16 days in healthy active adults. That is useful context, but it is not the Salidrosol blend dose and not a memory or focus protocol.
Timing & effect horizon
The pure salidroside study ran for 16 days. That is a study duration, not a guaranteed onset or cycle length for Salidrosol.
For the oral Rhodiola dry extracts described in the EMA monograph, people are directed to consult a qualified practitioner if symptoms continue beyond 2 weeks. That is medicine-specific context, not a cycle length or a limit established for Salidrosol.
No human onset, subjective-duration, The time for blood levels to fall by half during the final elimination phase.Source, or tolerance data were located for the tyrosol + salidroside sublingual blend. The empty timing card is intentional rather than a claim that the blend takes a specific time to act.
Safety, side effects and risk profile
Blend-specific activation and sleep-disruption rates are unavailable.
Rhodiola preparations have reported mild gastrointestinal adverse effects; blend-specific rates are unavailable.
United States regulatory context depends on product claims and formulation.
Direct human safety data for Salidrosol were not found. EMA lists headache, nausea, abdominal pain, diarrhoea, rash, and itching for the Rhodiola preparations in its monograph; that does not establish event rates for this formula.
No blend-specific pregnancy, lactation, pediatric, or medical-condition data were located. The EMA says pregnancy and lactation safety is not established for the Rhodiola preparations it covers; that context is indirect for Salidrosol.
Interactions and cautions
For its defined oral Rhodiola dry-extract preparations, the EMA monograph says no clinically relevant interactions have been observed. That does not establish interaction safety for this tyrosol + salidroside sublingual blend or multi-ingredient stacks.
Legal and regulatory status
United States, as of 2026: FDA distinguishes permitted structure/function claims from disease claims for dietary supplements. This retail listing does not establish that this specific tyrosol + salidroside formula meets US ingredient, labeling, or claim requirements.
How it compares
Product-label facts describe the sublingual blend; human clinical findings are for pure salidroside; EMA context is for Rhodiola root and rhizome preparations. Do not use one evidence stream as proof for another.
Practical buying and quality notes
- A useful Salidrosol listing should state tyrosol and salidroside amounts per serving, total bottle volume, serving size in mL or drops, batch testing, solvent/excipient details, and whether the dose is per serving or per day.1
- Rhodiola extracts contain multiple constituents and variable rosavins/salidroside ratios. Salidrosol is a narrower tyrosol + salidroside formula, so price-per-mg comparisons with Rhodiola capsules can mislead. For solutions, compare package price per 0.5 mL serving and per declared active; a generic price-per-gram figure can be misleading for low-dose liquids.4
FAQ
What is Salidrosol?
1On this page, Salidrosol is a tyrosol + salidroside sublingual solution. It is related to Rhodiola constituents, but it is not the same as whole Rhodiola extract or pure salidroside.
What is the Salidrosol dosage?
1The product-serving context is about 20 mg combined actives per 0.5 mL dose, or 40 mg/day if two doses are used. That is label math, not a proven nootropic dose.
How long does Salidrosol take to work?
5Reliable onset and effect-duration data for the blend were not found. Pure salidroside was studied for 16 days in one exploratory active-adult trial, while Rhodiola traditional-use guidance is separate.
Is Salidrosol the same as Rhodiola?
4No. Rhodiola rosea extract is a whole botanical preparation with many compounds. Salidrosol is a narrower formula centered on tyrosol and salidroside, so Rhodiola evidence is indirect.
Does Salidrosol improve focus or memory?
5There is no direct human evidence that this blend improves focus or memory. The better-supported human signal is limited and adjacent: salidroside exercise/fatigue research and Rhodiola stress-fatigue traditional use.
References
- Nootropics Depot. Salidrosol Sublingual Solution | Tyrosol + Salidroside product page. Accessed 2026-07-01.
- PubChem. Salidroside (CID 159278). Accessed 2026-07-01.
- PubChem. Tyrosol (CID 10393). Accessed 2026-07-01.
- European Medicines Agency. Rhodiolae roseae rhizoma et radix: herbal medicinal product summary. Accessed 2026-07-01.
- Schwarz NA, Stratton MT, Colquhoun RJ, et al. Salidroside and exercise performance in healthy active young adults: an exploratory, randomized, double-blind, placebo-controlled study. J Int Soc Sports Nutr. 2024;21(1):2433744.
- Tinsley GM, et al. Rhodiola rosea as an adaptogen to enhance exercise performance: a review of the literature. Br J Nutr. 2024;131(3):461-473.
- U.S. Food and Drug Administration. Structure/Function Claims. Accessed 2026-08-20.
- Combined Rhodiola rosea and eccentric training boost endurance performance and lower-limb reactive strength in recreationally active women. Front Physiol. 2025;16:1663086.